Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies

NCT05566756 · clinicaltrials.gov ↗

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

OTHER: Ofatumumab

Sponsor

Novartis Pharmaceuticals